Ajooni Biotech Limited announce contract agreement with National Dairy Development Board

New Delhi (India), April 15:  Ajooni Biotech Limited is pleased to announce a strategic partnership with the esteemed National Dairy Development Board (NDDB) Dairy Services. Through this partnership with NDDB, Ajooni Biotech Limited anticipates fresh orders to the tune of approximately Rs. 2 crore per month for cattle feed and an additional Rs. 2 crore per month for feed supplements. Consequently, the total revenue is expected to witness a monthly increase of Rs. 4 crore with a profit margin ranging between 10% to 15%.

Highlights:-

  • Ajooni Biotech Limited anticipates fresh orders to the tune of approximately Rs. 2 crore per month for cattle feed and an additional Rs. 2 crore per month for feed supplements
  • Consequently, the total revenue is expected to witness a monthly increase of Rs. 4 crore with a profit margin ranging between 10% to 15%.

With this collaboration, company will supply high-quality cattle feed and feed supplements to support NDDB’s efforts in enhancing the productivity of milk producer companies and promoting sustainable livelihoods among dairy farmers.

NDDB Dairy Services, a pivotal entity in India’s dairy industry, with 170 million unions operating across 285 districts and encompassing approximately 96,000 villages, they play a crucial role in the livelihoods of over 10.7 million farmers and labourers who are integral members of its network. This partnership underscores company’s commitment to contributing to the growth and welfare of India’s dairy sector by leveraging their expertise in providing superior cattle feed and supplements.

About Ajooni Biotech Limited

Ajooni Biotech Limited is a PURE VEG. animal health care solutions company. It stands as a trailblazer, innovator, and frontrunner in the realm of animal feed production, prioritizing excellence in quality, safety, and production innovation, along with a commitment to delivering exceptional customer service. With a comprehensive feed range, Ajooni has emerged as a significant player in the animal feed and aquaculture sectors. Opting for Ajooni signifies partnering with a responsive, attentive ally boasting extensive experience and a nuanced understanding of the intricate dynamics within the livestock market. Ajooni’s primary objective revolves around optimizing productivity, meeting animals’ nutritional requirements comprehensively, and attaining an optimal dietary balance. Ajooni aims to be a steadfast ally to farmers, with our team of experts offering their wealth of knowledge and years of experience to devise tailored diet programs and provide optimal recommendations for the sustained growth and advancement of livestock.

Ajooni Biotech Ltd. is driven to combine innovation and compassion to create value-driven products for all stakeholders.. Its focus is to leverage capabilities, to develop cost effective solutions to improve animal productivity and income of farmers. Godrej Agrovet is the only nearest competitor in the listed space for Ajooni Biotech Limited which gives it an edge for exponential growth in its products offerings

If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

aayush jain acquisition Business cashew processing cote d’ivoire esos 2026 pacific global fzco Pajson Agro pulkit jain Royal Mewa Share Swap

From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin

All-stock 100% acquisition | ₹354.52 crore | Board also approves ESOS 2026 New Delhi [India], November 6: Pajson Agro India Limited (PAJSON | 544657 | INE14LM01012), a vertically integrated cashew processing company with farm-gate sourcing across key producing origins and a growing consumer brand, ‘Royal Mewa’, has announced that its Board of Directors, has approved […]

Read More
Business Fredun Pharmaceuticals EBITDA Growth Fredun Pharmaceuticals H1 FY27 Results Fredun Pharmaceuticals Net Profit Fredun Pharmaceuticals Revenue Growth Indian pharmaceutical industry

Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27

Mumbai (Maharashtra) [India], November 6: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q2 & H1 FY27. The Company offers a diversified portfolio spanning generics, cosmeceuticals, nutraceuticals, mobility solutions, and animal healthcare products. Key Financial Highlights Standalone key Financial Highlights […]

Read More
Business

Patil Automation Marks a Strong First Half of FY27; Consolidated Revenue Up 37% YoY, Net Profit Up 48%

Mumbai (Maharashtra) [India], November 6: Patil Automation Limited (NSE: PATILAUTOM | INE17GV01016), a leading provider of turnkey welding, assembly and robotics-integrated automation solutions, has released its Unaudited Standalone and Consolidated Financial Results for the half year ended September 30, 2026, reporting broad-based growth across the group. Performance Snapshot – H1 FY27 H1 FY27 Key Financial […]

Read More